US Stock MarketDetailed Quotes

EVFM Evofem Biosciences

Watchlist
  • 0.009
  • -0.001-11.43%
15min DelayTrading Jul 22 12:02 ET
577.16KMarket Cap0.01P/E (TTM)

Evofem Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
102.49%123K
87.26%-8.97M
97.40%-170K
85.50%-2.36M
94.40%-1.49M
76.39%-4.94M
51.99%-70.41M
69.29%-6.53M
56.38%-16.3M
50.24%-26.66M
Net income from continuing operations
-104.29%-4.81M
169.07%52.98M
74.64%-2.11M
-26.26%66.01M
93.21%-8.56M
92.62%-2.35M
62.62%-76.7M
83.83%-8.34M
220.85%89.51M
-276.89%-125.98M
Operating gains losses
2,471.43%2.16M
-168.89%-68.15M
-95.26%47K
-376.09%-70.16M
-97.34%1.89M
-95.00%84K
--98.92M
--991K
--25.41M
--70.84M
Depreciation and amortization
-92.12%59K
-12.95%1.78M
3.51%1.33M
-85.20%37K
-232.40%-331K
182.64%749K
100.00%2.05M
349.47%1.28M
-6.72%250K
-9.09%250K
Other non cash items
-0.18%564K
-44.37%1.8M
-228.68%-691K
108.16%612K
-11.78%1.32M
-38.45%565K
-20.30%3.24M
-39.12%537K
-65.97%294K
77.65%1.49M
Change In working capital
197.31%2.71M
-21.44%4.73M
-6.09%4.29M
-266.85%-619K
189.12%3.85M
-151.60%-2.79M
-43.11%6.02M
-68.64%4.56M
-92.53%371K
71.85%-4.32M
-Change in receivables
122.81%1.43M
-186.64%-4.61M
-94.98%584K
79.41%-1.12M
176.39%2.21M
-408.80%-6.28M
198.90%5.32M
581.27%11.64M
-491.44%-5.46M
-1,388.66%-2.89M
-Change in inventory
494.95%391K
34.48%2.11M
181.59%758K
-137.46%-357K
129.22%1.8M
-113.11%-99K
7,557.14%1.57M
-149.23%-929K
16.65%953K
175.02%787K
-Change in prepaid assets
-62.25%573K
41.19%3.66M
-29.74%430K
-83.17%796K
153.53%917K
246.53%1.52M
-81.32%2.59M
-95.43%612K
59.85%4.73M
89.35%-1.71M
-Change in payables and accrued expense
-108.32%-288K
1,154.62%4.62M
158.49%1.77M
-126.89%-160K
46.65%-454K
-5.18%3.46M
-93.27%368K
-211.13%-3.03M
-61.86%595K
-176.12%-851K
-Change in other current liabilities
92.22%-46K
-9.16%-1.48M
95.73%-46K
-122.92%-44K
-26,466.67%-797K
-26.82%-591K
10.15%-1.35M
-147.02%-1.08M
144.86%192K
99.28%-3K
-Change in other working capital
181.50%652K
117.51%434K
129.73%789K
142.19%270K
-49.57%175K
-270.58%-800K
-33.15%-2.48M
-342.33%-2.65M
-165.24%-640K
-72.63%347K
Cash from discontinued investing activities
Operating cash flow
102.49%123K
87.26%-8.97M
97.40%-170K
85.50%-2.36M
94.40%-1.49M
76.39%-4.94M
51.99%-70.41M
69.29%-6.53M
56.38%-16.3M
50.24%-26.66M
Investing cash flow
Cash flow from continuing investing activities
-366.67%-14K
98.83%-4K
0
0
99.41%-1K
95.45%-3K
87.32%-341K
33.96%-35K
88.27%-70K
87.25%-170K
Net PPE purchase and sale
-366.67%-14K
98.83%-4K
--0
--0
99.41%-1K
95.45%-3K
88.40%-341K
33.96%-35K
88.27%-70K
87.25%-170K
Cash from discontinued investing activities
Investing cash flow
-366.67%-14K
98.83%-4K
--0
--0
99.41%-1K
95.45%-3K
87.32%-341K
33.96%-35K
88.27%-70K
87.25%-170K
Financing cash flow
Cash flow from continuing financing activities
0
-92.29%4.78M
-77.33%340K
-45.82%2.14M
-98.56%597K
-88.76%1.7M
-31.70%61.94M
-84.80%1.5M
24,562.50%3.95M
-21.67%41.36M
Net issuance payments of debt
--0
-20.01%4.49M
-85.07%224K
--2.12M
108.45%498K
-83.60%1.64M
--5.61M
--1.5M
--0
---5.89M
Net common stock issuance
----
--0
--0
--0
----
----
-60.38%32.3M
--0
--0
-49.85%26.82M
Proceeds from stock option exercised by employees
--0
-98.85%290K
--116K
-99.67%14K
-99.53%99K
--61K
5,433.11%25.23M
--0
3,799.09%4.29M
--20.94M
Net other financing activities
----
----
----
----
----
----
7.32%-1.2M
--0
-261.05%-343K
44.96%-508K
Cash from discontinued financing activities
Financing cash flow
--0
-92.29%4.78M
-77.33%340K
-45.82%2.14M
-98.56%597K
-88.76%1.7M
-31.70%61.94M
-84.80%1.5M
24,562.50%3.95M
-21.67%41.36M
Net cash flow
Beginning cash position
-87.86%580K
-64.85%4.78M
-95.83%410K
-97.14%636K
-80.16%1.53M
-64.85%4.78M
-81.19%13.59M
-60.69%9.84M
-64.65%22.27M
-88.12%7.73M
Current changes in cash
103.36%109K
52.38%-4.2M
103.36%170K
98.18%-226K
-106.18%-898K
44.64%-3.24M
84.98%-8.81M
55.76%-5.07M
67.26%-12.42M
790.45%14.53M
End cash Position
-55.08%689K
-87.86%580K
-87.86%580K
-95.83%410K
-97.14%636K
-80.16%1.53M
-64.85%4.78M
-64.85%4.78M
-60.69%9.84M
-64.65%22.27M
Free cash flow
102.21%109K
87.32%-8.97M
97.41%-170K
85.56%-2.36M
94.43%-1.5M
76.45%-4.94M
52.71%-70.75M
69.20%-6.57M
56.88%-16.37M
51.14%-26.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 102.49%123K87.26%-8.97M97.40%-170K85.50%-2.36M94.40%-1.49M76.39%-4.94M51.99%-70.41M69.29%-6.53M56.38%-16.3M50.24%-26.66M
Net income from continuing operations -104.29%-4.81M169.07%52.98M74.64%-2.11M-26.26%66.01M93.21%-8.56M92.62%-2.35M62.62%-76.7M83.83%-8.34M220.85%89.51M-276.89%-125.98M
Operating gains losses 2,471.43%2.16M-168.89%-68.15M-95.26%47K-376.09%-70.16M-97.34%1.89M-95.00%84K--98.92M--991K--25.41M--70.84M
Depreciation and amortization -92.12%59K-12.95%1.78M3.51%1.33M-85.20%37K-232.40%-331K182.64%749K100.00%2.05M349.47%1.28M-6.72%250K-9.09%250K
Other non cash items -0.18%564K-44.37%1.8M-228.68%-691K108.16%612K-11.78%1.32M-38.45%565K-20.30%3.24M-39.12%537K-65.97%294K77.65%1.49M
Change In working capital 197.31%2.71M-21.44%4.73M-6.09%4.29M-266.85%-619K189.12%3.85M-151.60%-2.79M-43.11%6.02M-68.64%4.56M-92.53%371K71.85%-4.32M
-Change in receivables 122.81%1.43M-186.64%-4.61M-94.98%584K79.41%-1.12M176.39%2.21M-408.80%-6.28M198.90%5.32M581.27%11.64M-491.44%-5.46M-1,388.66%-2.89M
-Change in inventory 494.95%391K34.48%2.11M181.59%758K-137.46%-357K129.22%1.8M-113.11%-99K7,557.14%1.57M-149.23%-929K16.65%953K175.02%787K
-Change in prepaid assets -62.25%573K41.19%3.66M-29.74%430K-83.17%796K153.53%917K246.53%1.52M-81.32%2.59M-95.43%612K59.85%4.73M89.35%-1.71M
-Change in payables and accrued expense -108.32%-288K1,154.62%4.62M158.49%1.77M-126.89%-160K46.65%-454K-5.18%3.46M-93.27%368K-211.13%-3.03M-61.86%595K-176.12%-851K
-Change in other current liabilities 92.22%-46K-9.16%-1.48M95.73%-46K-122.92%-44K-26,466.67%-797K-26.82%-591K10.15%-1.35M-147.02%-1.08M144.86%192K99.28%-3K
-Change in other working capital 181.50%652K117.51%434K129.73%789K142.19%270K-49.57%175K-270.58%-800K-33.15%-2.48M-342.33%-2.65M-165.24%-640K-72.63%347K
Cash from discontinued investing activities
Operating cash flow 102.49%123K87.26%-8.97M97.40%-170K85.50%-2.36M94.40%-1.49M76.39%-4.94M51.99%-70.41M69.29%-6.53M56.38%-16.3M50.24%-26.66M
Investing cash flow
Cash flow from continuing investing activities -366.67%-14K98.83%-4K0099.41%-1K95.45%-3K87.32%-341K33.96%-35K88.27%-70K87.25%-170K
Net PPE purchase and sale -366.67%-14K98.83%-4K--0--099.41%-1K95.45%-3K88.40%-341K33.96%-35K88.27%-70K87.25%-170K
Cash from discontinued investing activities
Investing cash flow -366.67%-14K98.83%-4K--0--099.41%-1K95.45%-3K87.32%-341K33.96%-35K88.27%-70K87.25%-170K
Financing cash flow
Cash flow from continuing financing activities 0-92.29%4.78M-77.33%340K-45.82%2.14M-98.56%597K-88.76%1.7M-31.70%61.94M-84.80%1.5M24,562.50%3.95M-21.67%41.36M
Net issuance payments of debt --0-20.01%4.49M-85.07%224K--2.12M108.45%498K-83.60%1.64M--5.61M--1.5M--0---5.89M
Net common stock issuance ------0--0--0---------60.38%32.3M--0--0-49.85%26.82M
Proceeds from stock option exercised by employees --0-98.85%290K--116K-99.67%14K-99.53%99K--61K5,433.11%25.23M--03,799.09%4.29M--20.94M
Net other financing activities ------------------------7.32%-1.2M--0-261.05%-343K44.96%-508K
Cash from discontinued financing activities
Financing cash flow --0-92.29%4.78M-77.33%340K-45.82%2.14M-98.56%597K-88.76%1.7M-31.70%61.94M-84.80%1.5M24,562.50%3.95M-21.67%41.36M
Net cash flow
Beginning cash position -87.86%580K-64.85%4.78M-95.83%410K-97.14%636K-80.16%1.53M-64.85%4.78M-81.19%13.59M-60.69%9.84M-64.65%22.27M-88.12%7.73M
Current changes in cash 103.36%109K52.38%-4.2M103.36%170K98.18%-226K-106.18%-898K44.64%-3.24M84.98%-8.81M55.76%-5.07M67.26%-12.42M790.45%14.53M
End cash Position -55.08%689K-87.86%580K-87.86%580K-95.83%410K-97.14%636K-80.16%1.53M-64.85%4.78M-64.85%4.78M-60.69%9.84M-64.65%22.27M
Free cash flow 102.21%109K87.32%-8.97M97.41%-170K85.56%-2.36M94.43%-1.5M76.45%-4.94M52.71%-70.75M69.20%-6.57M56.88%-16.37M51.14%-26.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg